company background image
STHZ

StateHouse Holdings CNSX:STHZ Stock Report

Last Price

CA$0.21

Market Cap

CA$53.0m

7D

-31.1%

1Y

-80.2%

Updated

27 Sep, 2022

Data

Company Financials +
STHZ fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health2/6
Dividends0/6

STHZ Stock Overview

StateHouse Holdings Inc. engages in the cultivation, processing, manufacturing, distribution, and retail of cannabis products for the adult-use and medical markets in the United States.

StateHouse Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for StateHouse Holdings
Historical stock prices
Current Share PriceCA$0.21
52 Week HighCA$1.08
52 Week LowCA$0.21
Beta1.51
1 Month Change-50.00%
3 Month Change-43.24%
1 Year Change-80.19%
3 Year Change-88.40%
5 Year Changen/a
Change since IPO-95.92%

Recent News & Updates

Shareholder Returns

STHZCA PharmaceuticalsCA Market
7D-31.1%-10.6%-5.5%
1Y-80.2%-67.6%-7.3%

Return vs Industry: STHZ underperformed the Canadian Pharmaceuticals industry which returned -67.8% over the past year.

Return vs Market: STHZ underperformed the Canadian Market which returned -8.4% over the past year.

Price Volatility

Is STHZ's price volatile compared to industry and market?
STHZ volatility
STHZ Average Weekly Movement19.5%
Pharmaceuticals Industry Average Movement11.8%
Market Average Movement9.8%
10% most volatile stocks in CA Market18.1%
10% least volatile stocks in CA Market3.8%

Stable Share Price: STHZ is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 19% a week.

Volatility Over Time: STHZ's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
2006n/an/ahttps://www.statehouseholdings.com

StateHouse Holdings Inc. engages in the cultivation, processing, manufacturing, distribution, and retail of cannabis products for the adult-use and medical markets in the United States. It operates 14 dispensaries covering Northern and Southern California and one in Oregon. The company was formerly known as Harborside Inc. and changed its name to StateHouse Holdings Inc. in July 2022.

StateHouse Holdings Fundamentals Summary

How do StateHouse Holdings's earnings and revenue compare to its market cap?
STHZ fundamental statistics
Market CapCA$53.00m
Earnings (TTM)-CA$67.17m
Revenue (TTM)CA$116.02m

0.5x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
STHZ income statement (TTM)
RevenueUS$84.37m
Cost of RevenueUS$52.73m
Gross ProfitUS$31.64m
Other ExpensesUS$80.48m
Earnings-US$48.84m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.19
Gross Margin37.50%
Net Profit Margin-57.89%
Debt/Equity Ratio110.1%

How did STHZ perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is STHZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for STHZ?

Other financial metrics that can be useful for relative valuation.

STHZ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.9x
Enterprise Value/EBITDA-11.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does STHZ's PS Ratio compare to its peers?

STHZ PS Ratio vs Peers
The above table shows the PS ratio for STHZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.6x
TILT TILT Holdings
0.3x21.3%CA$69.5m
VLNS Valens
0.9x21.4%CA$76.6m
TIUM.U Cansortium
0.6x27.3%US$42.9m
VEXT Vext Science
0.7x23.8%CA$37.4m
STHZ StateHouse Holdings
0.5x59.0%CA$53.0m

Price-To-Sales vs Peers: STHZ is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (0.6x).


Price to Earnings Ratio vs Industry

How does STHZ's PE Ratio compare vs other companies in the CA Pharmaceuticals Industry?

Price-To-Sales vs Industry: STHZ is good value based on its Price-To-Sales Ratio (0.5x) compared to the Canadian Pharmaceuticals industry average (1.3x)


Price to Sales Ratio vs Fair Ratio

What is STHZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

STHZ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.5x
Fair PS Ratio7.3x

Price-To-Sales vs Fair Ratio: STHZ is good value based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (7.3x).


Share Price vs Fair Value

What is the Fair Price of STHZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate STHZ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate STHZ's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies

Future Growth

How is StateHouse Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


59.0%

Forecasted annual revenue growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if STHZ's forecast earnings growth is above the savings rate (1.6%).

Earnings vs Market: Insufficient data to determine if STHZ's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if STHZ's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: STHZ's revenue (59% per year) is forecast to grow faster than the Canadian market (5.8% per year).

High Growth Revenue: STHZ's revenue (59% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if STHZ's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Past Performance

How has StateHouse Holdings performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-17.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: STHZ is currently unprofitable.

Growing Profit Margin: STHZ is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: STHZ is unprofitable, and losses have increased over the past 5 years at a rate of 17.2% per year.

Accelerating Growth: Unable to compare STHZ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: STHZ is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (39.8%).


Return on Equity

High ROE: STHZ has a negative Return on Equity (-47.11%), as it is currently unprofitable.


Discover strong past performing companies

Financial Health

How is StateHouse Holdings's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: STHZ's short term assets ($65.7M) do not cover its short term liabilities ($131.9M).

Long Term Liabilities: STHZ's short term assets ($65.7M) do not cover its long term liabilities ($158.1M).


Debt to Equity History and Analysis

Debt Level: STHZ's net debt to equity ratio (91.1%) is considered high.

Reducing Debt: STHZ's debt to equity ratio has reduced from 555.3% to 110.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: STHZ has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: STHZ has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 5.6% each year.


Discover healthy companies

Dividend

What is StateHouse Holdings's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

StateHouse Holdings Dividend Yield vs Market
How does StateHouse Holdings dividend yield compare to the market?
SegmentDividend Yield
Company (StateHouse Holdings)n/a
Market Bottom 25% (CA)2.1%
Market Top 25% (CA)6.1%
Industry Average (Pharmaceuticals)2.6%
Analyst forecast in 3 Years (StateHouse Holdings)n/a

Notable Dividend: Unable to evaluate STHZ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate STHZ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if STHZ's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if STHZ's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as STHZ has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

StateHouse Holdings has no CEO, or we have no data on them.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: STHZ insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

CNSX:STHZ Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Jun 22BuyCA$7,406Thomas DiGiovanniIndividual20,000CA$0.37
22 Jun 22BuyCA$7,761Thomas DiGiovanniIndividual20,000CA$0.39
16 Jun 22BuyCA$2,446Edward SchmultsIndividual6,000CA$0.41
02 Jun 22BuyCA$119,169Andrew SturnerIndividual227,000CA$0.60
29 Apr 22BuyCA$6,710,992Entourage Effect Capital, LLCCompany14,960,957CA$0.45
01 Mar 22BuyCA$4,998,980Entourage Effect Capital, LLCCompany4,158,890CA$1.20

Ownership Breakdown

What is the ownership structure of STHZ?
Owner TypeNumber of SharesOwnership Percentage
Institutions644,1000.3%
Private Companies11,397,5894.5%
Individual Insiders14,021,6965.6%
VC/PE Firms25,520,89510.1%
General Public200,815,12979.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 207.6%.


Top Shareholders

Top 20 shareholders own 20.44% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.11%
Entourage Effect Capital, LLC
25,520,895$5.4m203.25%100%
4.44%
Roger Jenkins
11,201,699$2.4m0%no data
4.42%
Linneaus Management Services, LLC
11,156,626$2.3m0%no data
0.22%
Kevin Albert
547,477$115.0k0%no data
0.2%
John Nichols
500,000$105.0k0%no data
0.18%
Ahmer Iqbal
460,357$96.7k0%no data
0.15%
Matthew Hawkins
385,892$81.0k0%no data
0.14%
Andrew Sturner
352,100$73.9k181.45%no data
0.12%
Peter Bilodeau
293,271$61.6k0%no data
0.095%
Murray Fields & Company Llc
240,963$50.6k0%no data
0.079%
Purpose Investments Inc.
200,000$42.0k0%no data
0.069%
Arrow Capital Management Inc.
175,000$36.8k0%0.01%
0.063%
The Scott Company, LLC
160,000$33.6k0%no data
0.063%
James Scott
160,000$33.6k0%no data
0.03%
Thomas DiGiovanni
75,700$15.9k112.04%no data
0.03%
Gofen and Glossberg, L.L.C.
75,000$15.8k0%no data
0.016%
Peter Kampian
39,200$8.2k0%no data
0.0069%
Moloney Securities Asset Management LLC
17,500$3.7k0%no data
0.0066%
SVB Wealth LLC
16,600$3.5k0%no data
0.0024%
Edward Schmults
6,000$1.3k0%no data

Company Information

StateHouse Holdings Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: StateHouse Holdings Inc.
  • Ticker: STHZ
  • Exchange: CNSX
  • Founded: 2006
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: CA$53.004m
  • Shares outstanding: 252.40m
  • Website: https://www.statehouseholdings.com

Location

  • StateHouse Holdings Inc.
  • 1295 West Morena Blvd
  • San Diego
  • California
  • 92110
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
STHZ.FOTCPK (Pink Sheets LLC)YesSubordinate Voting SharesUSUSDJun 2019
STHZCNSX (Canadian National Stock Exchange)YesSubordinate Voting SharesCACADJun 2019

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/27 00:00
End of Day Share Price2022/09/27 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.